NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma
Vasiliki Leventaki(The University of Texas MD Anderson Cancer Center), George Z. Rassidakis(Karolinska University Hospital)
Cited by 83
Related Papers
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3- mutated acute myeloid leukemia cells
|Molecular Cancer|2010|105
Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis
|Modern Pathology|2004|24